Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

USANA Health Sciences Inc Issues FY 2013 Guidance Above Analysts' Estimates


Tuesday, 5 Feb 2013 04:07pm EST 

USANA Health Sciences Inc announced that for fiscal 2013, it expects consolidated net sales between $700 million and $720 million and earnings per share (EPS) of between $5.10 and $5.25. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $690 million and EPS of $4.84 for fiscal 2013. 

Company Quote

107.0
-1.1 -1.02%
25 Nov 2014